文献速递中医妇科中药与中成药合理使用

益母草注射液与肌注缩宫素预防剖宫产后出血的真实世界研究

Effects of Motherwort Injection Versus Intramuscular Oxytocin for Preventing Postpartum Hemorrhage Among Women Who Underwent Cesarean Section.
PubMed 文献 · Front Pharmacol · 2022-03-21

本研究基于妊娠登记数据库开展倾向性评分匹配的活性对照队列研究,纳入剖宫产且静脉用缩宫素的产妇,比较宫体注射益母草注射液与肌注缩宫素预防产后出血的效果。匹配后分析显示,益母草组产后出血和严重产后出血风险均显著低于肌注缩宫素组。

要点

  • 在静脉缩宫素基础上,加用益母草注射液较加用肌注缩宫素降低产后出血风险。
  • 益母草组严重产后出血风险亦显著低于肌注缩宫素组。
  • 结果来自真实世界队列,需结合临床个体化评估。

核心结论

  • 剖宫产且已静脉用缩宫素的产妇中,加用宫体注射益母草注射液比加用肌注缩宫素产后出血风险更低。

研究设计与样本

  • 活性对照、倾向性评分匹配的队列研究,使用妊娠登记数据库。
  • 共22,519例剖宫产产妇,益母草组586例(2.60%),肌注缩宫素组21,933例(97.40%)。
  • 采用1:1倾向性评分匹配平衡基线特征,逻辑回归估计风险差和比值比。

主要发现

  • 总体产后出血4,081例(18.12%),严重产后出血480例(2.13%)。
  • 匹配后益母草组产后出血风险差-25.26%(95%CI -30.04%至-20.47%,p<0.001),OR 0.25(95%CI 0.18至0.32,p<0.001)。
  • 匹配后严重产后出血风险差-3.58%(95%CI -5.87%至-1.30%,p<0.001),OR 0.39(95%CI 0.20至0.71,p<0.002)。
  • 四项敏感性分析结果与主分析相似。

关键数值与推荐

  • 主要结局为产后2小时内出血量超过500 ml(产后出血)。
  • 次要结局为出血量超过1,000 ml(严重产后出血)。

临床怎么用

  • 对剖宫产且术中已静脉用缩宫素的产妇,可考虑宫体注射益母草注射液作为预防产后出血的附加用药选择。

局限性

  • 原文摘要未报告具体局限性信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objectives: Subject to ethical constraints, real-world data are an important resource for evaluating treatment effects of medication use during pregnancy and the postpartum period. This study investigated whether motherwort injection, a traditional Chinese medicine preparation, was more effective than intramuscular (IM) oxytocin for preventing postpartum hemorrhage (PPH) in a real-world setting when intravenous (IV) oxytocin is administered. Methods: We conducted an active-controlled, propensity-score matched cohort study using an established pregnancy registry database. Women who underwent cesarean section and received IV oxytocin at the third stage of labor were included. We used an active-comparator design to minimize indication bias, in which we compared IM motherwort injection in the uterus versus IM oxytocin, both on top of IV oxytocin use. We applied 1:1 propensity-score matching (PSM) to balance patient baseline characteristics and used a logistic regression model to estimate treatment effect (i.e., risk difference (RD) and odds ratio (OR)) by using the counterfactual framework. The outcomes of interest were blood loss over 500 ml within 2 h after delivery (PPH, primary) and blood loss over 1,000 ml (severe PPH, secondary). We conducted four sensitivity analyses to examine the robustness of the results. Results: A total of 22,519 pregnant women underwent cesarean sections, among which 4,081 (18.12%) PPH and 480 (2.13%) severe PPH occurred. Among included women, 586 (2.60%) were administrated with IM motherwort injection, and 21,933 (97.40%) used IM oxytocin. After PSM, patient baseline characteristics were well balanced. Compared with IM oxytocin, the use of IM motherwort injection was associated with significantly lower risk of PPH (RD -25.26%, 95% CI -30.04% to -20.47%, p < 0.001; OR 0.25, 95% CI 0.18 to 0.32, p < 0.001) and severe PPH (RD -3.58%, 95% CI -5.87% to -1.30%, p < 0.001; OR 0.39, 95% CI 0.20 to 0.71, p < 0.002). Sensitivity analyses showed that the results were similar. Conclusion: With the use of data from a real-world setting, the findings consistently showed that among women undergoing cesarean section who had received IV oxytocin, the additional use of IM motherwort injection could achieve a lower risk of PPH as compared to the additional use of IM oxytocin. Our study suggested a paradigm for investigating the treatment effect of Chinese herbal medicine in the real-world practice setting.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Li MX, Liu CR, Chen M, et al. Effects of Motherwort Injection Versus Intramuscular Oxytocin for Preventing Postpartum Hemorrhage Among Women Who Underwent Cesarean Section. Front Pharmacol. 2022. PMID: 35401190. doi:10.3389/fphar.2022.859495

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。